SEI Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Buy
272,103
+90,115
+50% +$12.6M 0.03% 592
2025
Q4
$29.8M Sell
181,988
-33,048
-15% -$5.18M 0.03% 576
2025
Q3
$28.7M Sell
215,036
-13,439
-6% -$1.63M 0.03% 566
2025
Q2
$28.4M Sell
228,475
-22,243
-9% -$2.83M 0.03% 548
2025
Q1
$31.9M Buy
250,718
+31,114
+14% +$4.79M 0.04% 477
2024
Q4
$31.6M Buy
219,604
+24,662
+13% +$3.54M 0.04% 463
2024
Q3
$29M Buy
194,942
+7,399
+4% +$1.06M 0.04% 513
2024
Q2
$23.6M Sell
187,543
-31,171
-14% -$4.89M 0.03% 540
2024
Q1
$40.2M Sell
218,714
-40,227
-16% -$7.66M 0.06% 354
2023
Q4
$46.6M Buy
258,941
+7,064
+3% +$1.1M 0.07% 294
2023
Q3
$40.1M Buy
251,877
+64,774
+35% +$10.6M 0.07% 296
2023
Q2
$26.5M Buy
187,103
+48,061
+35% +$7.71M 0.05% 448
2023
Q1
$23.4M Buy
139,042
+356
+0.3% +$63.5K 0.04% 476
2022
Q4
$23.5M Sell
138,686
-8,984
-6% -$1.63M 0.05% 406
2022
Q3
$27.6M Buy
147,670
+35,904
+32% +$7.57M 0.06% 356
2022
Q2
$18.1M Buy
111,766
+51,849
+87% +$8.2M 0.04% 493
2022
Q1
$11.3M Buy
59,917
+9,352
+18% +$1.78M 0.02% 716
2021
Q4
$13.4M Buy
50,565
+8,963
+22% +$2.41M 0.03% 655
2021
Q3
$11.9M Buy
41,602
+13,684
+49% +$3.51M 0.03% 672
2021
Q2
$5.57M Buy
27,918
+5,807
+26% +$1.13M 0.01% 1022
2021
Q1
$4.28M Buy
22,111
+9,806
+80% +$2.01M 0.01% 1100
2020
Q4
$2.36M Sell
12,305
-3,867
-24% -$704K 0.01% 1310
2020
Q3
$2.38M Buy
16,172
+6,472
+67% +$925K 0.01% 1205
2020
Q2
$1.2M Sell
9,700
-13,403
-58% -$1.58M ﹤0.01% 1484
2020
Q1
$2.23M Buy
23,103
+3,531
+18% +$341K 0.01% 1098
2019
Q4
$1.81M Sell
19,572
-389
-2% -$32.7K 0.01% 1385
2019
Q3
$1.54M Buy
19,961
+114
+0.6% +$9.97K ﹤0.01% 1433
2019
Q2
$1.7M Buy
19,847
+16,547
+501% +$1.13M 0.01% 1383
2019
Q1
$198K Sell
3,300
-45,085
-93% -$2.59M ﹤0.01% 2291
2018
Q4
$2.63M Buy
48,385
+17,983
+59% +$1.05M 0.01% 1188
2018
Q3
$1.69M Sell
30,402
-50,335
-62% -$2.59M 0.01% 1314
2018
Q2
$3.8M Sell
80,737
-3,100
-4% -$128K 0.01% 1056
2018
Q1
$3.03M Sell
83,837
-83,787
-50% -$2.95M 0.01% 1049
2017
Q4
$6.08M Buy
167,624
+9,124
+6% +$330K 0.02% 816
2017
Q3
$6.07M Buy
158,500
+3,500
+2% +$147K 0.02% 798
2017
Q2
$6.42M Buy
155,000
+28,400
+22% +$1.08M 0.03% 730
2017
Q1
$4.46M Buy
126,600
+41,600
+49% +$1.32M 0.02% 849
2016
Q4
$2.62M Buy
85,000
+70
+0.1% +$2.17K 0.01% 1050
2016
Q3
$2.56M Buy
84,930
+84,045
+9,497% +$2.54M 0.01% 993
2016
Q2
$24K Buy
885
+525
+146% +$13.4K ﹤0.01% 2120
2016
Q1
$10K Buy
+360
New +$8.81K ﹤0.01% 2190
2015
Q4
Sell
-15,244
Closed -$425K 2653
2015
Q3
$425K Buy
+15,244
New +$551K ﹤0.01% 1349

Other funds holding RGEN

SEI Investments's RGEN Position: Q1 2026 in Review

SEI Investments increased its Repligen (RGEN) stake by 50% in Q1 2026, buying an estimated $12.6M and bringing the position to 272,103 shares worth $32.1M. The position accounts for 0.03% of the portfolio, ranked #592.

SEI Investments first reported a position in RGEN in Q3 2015 and has held it in 42 quarters since. The position peaked at $46.6M in Q4 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • SEI Investments held 272,103 shares of Repligen worth $32.1M as of Q1 2026.
  • SEI Investments bought 90,115 Repligen shares in Q1 2026, an estimated $12.6M.
  • Repligen made up 0.03% of SEI Investments's portfolio in Q1 2026, its #592 holding.
  • SEI Investments first reported a position in Repligen in Q3 2015 and has held it in 42 quarters since.
  • SEI Investments's Repligen position peaked at $46.6M in Q4 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.